

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 5.37491885 |
| 2 | epithelial cilium movement (GO:0003351) | 5.30696354 |
| 3 | cilium movement (GO:0003341) | 5.30579588 |
| 4 | negative T cell selection (GO:0043383) | 4.76681533 |
| 5 | tolerance induction (GO:0002507) | 4.68550130 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.51621609 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.48912752 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.48912752 |
| 9 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.46713772 |
| 10 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.40315231 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.38694051 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 4.38694051 |
| 13 | negative thymic T cell selection (GO:0045060) | 4.36221819 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.25638168 |
| 15 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.21120058 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.16881767 |
| 17 | interferon-gamma production (GO:0032609) | 4.13560800 |
| 18 | positive T cell selection (GO:0043368) | 4.12397436 |
| 19 | desmosome organization (GO:0002934) | 4.02230150 |
| 20 | activated T cell proliferation (GO:0050798) | 4.02021728 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.00564633 |
| 22 | response to interleukin-15 (GO:0070672) | 3.97906029 |
| 23 | L-phenylalanine metabolic process (GO:0006558) | 3.94312850 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.94312850 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.93127212 |
| 26 | fatty acid elongation (GO:0030497) | 3.83925572 |
| 27 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.79702022 |
| 28 | thymic T cell selection (GO:0045061) | 3.78522811 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 3.78433930 |
| 30 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.77749673 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.74323459 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.74323459 |
| 33 | motile cilium assembly (GO:0044458) | 3.71761674 |
| 34 | negative regulation of bone resorption (GO:0045779) | 3.68636568 |
| 35 | T cell selection (GO:0045058) | 3.59966017 |
| 36 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.56208980 |
| 37 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.52568146 |
| 38 | creatine metabolic process (GO:0006600) | 3.51223049 |
| 39 | intestinal cholesterol absorption (GO:0030299) | 3.49420335 |
| 40 | COPI coating of Golgi vesicle (GO:0048205) | 3.47875219 |
| 41 | Golgi transport vesicle coating (GO:0048200) | 3.47875219 |
| 42 | T cell migration (GO:0072678) | 3.36599049 |
| 43 | signal peptide processing (GO:0006465) | 3.36314096 |
| 44 | axon ensheathment in central nervous system (GO:0032291) | 3.34459588 |
| 45 | central nervous system myelination (GO:0022010) | 3.34459588 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.33055578 |
| 47 | COPII vesicle coating (GO:0048208) | 3.27788387 |
| 48 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.24922287 |
| 49 | axoneme assembly (GO:0035082) | 3.18944717 |
| 50 | T cell receptor signaling pathway (GO:0050852) | 3.17712468 |
| 51 | endocrine pancreas development (GO:0031018) | 3.15169137 |
| 52 | regulation of extracellular matrix disassembly (GO:0010715) | 3.14322697 |
| 53 | alpha-linolenic acid metabolic process (GO:0036109) | 3.13756177 |
| 54 | regulation of chronic inflammatory response (GO:0002676) | 3.06942612 |
| 55 | aromatic amino acid family catabolic process (GO:0009074) | 3.05930156 |
| 56 | leukocyte aggregation (GO:0070486) | 3.01488567 |
| 57 | valine metabolic process (GO:0006573) | 3.00175179 |
| 58 | regulation of cholesterol homeostasis (GO:2000188) | 2.99267910 |
| 59 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.97054997 |
| 60 | cholesterol biosynthetic process (GO:0006695) | 2.94669884 |
| 61 | skin morphogenesis (GO:0043589) | 2.94080377 |
| 62 | pericardium development (GO:0060039) | 2.89971459 |
| 63 | positive regulation of interleukin-2 production (GO:0032743) | 2.89910333 |
| 64 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.89586872 |
| 65 | macroautophagy (GO:0016236) | 2.89030084 |
| 66 | negative regulation of bone remodeling (GO:0046851) | 2.88587935 |
| 67 | very long-chain fatty acid metabolic process (GO:0000038) | 2.88036299 |
| 68 | negative regulation of tissue remodeling (GO:0034104) | 2.84717541 |
| 69 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.83936189 |
| 70 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.83903238 |
| 71 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.83594900 |
| 72 | response to muramyl dipeptide (GO:0032495) | 2.83566268 |
| 73 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.82775932 |
| 74 | T cell costimulation (GO:0031295) | 2.78890157 |
| 75 | viral protein processing (GO:0019082) | 2.75229926 |
| 76 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.74683715 |
| 77 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.73869946 |
| 78 | positive regulation of tolerance induction (GO:0002645) | 2.71593944 |
| 79 | heterotypic cell-cell adhesion (GO:0034113) | 2.71266070 |
| 80 | negative regulation of interleukin-1 production (GO:0032692) | 2.71195893 |
| 81 | lymphocyte costimulation (GO:0031294) | 2.70522692 |
| 82 | intestinal absorption (GO:0050892) | 2.68501100 |
| 83 | nucleotide transmembrane transport (GO:1901679) | 2.67886738 |
| 84 | hemidesmosome assembly (GO:0031581) | 2.66669080 |
| 85 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.65307622 |
| 86 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.65120307 |
| 87 | amyloid precursor protein catabolic process (GO:0042987) | 2.64271737 |
| 88 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.62118524 |
| 89 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.60846348 |
| 90 | sphingoid metabolic process (GO:0046519) | 2.59881408 |
| 91 | ADP metabolic process (GO:0046031) | 2.59876679 |
| 92 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.58914357 |
| 93 | T-helper cell differentiation (GO:0042093) | 2.58914357 |
| 94 | sulfur amino acid catabolic process (GO:0000098) | 2.57401397 |
| 95 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.55611453 |
| 96 | cysteine metabolic process (GO:0006534) | 2.54175038 |
| 97 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.52888512 |
| 98 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.52183510 |
| 99 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.50953510 |
| 100 | smooth muscle tissue development (GO:0048745) | 2.50680223 |
| 101 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.49839679 |
| 102 | regulation of cholesterol metabolic process (GO:0090181) | 2.48322980 |
| 103 | ensheathment of neurons (GO:0007272) | 2.47914398 |
| 104 | axon ensheathment (GO:0008366) | 2.47914398 |
| 105 | protein K11-linked deubiquitination (GO:0035871) | 2.47334909 |
| 106 | phospholipid efflux (GO:0033700) | 2.47145900 |
| 107 | myelination (GO:0042552) | 2.46767190 |
| 108 | bile acid biosynthetic process (GO:0006699) | 2.46440247 |
| 109 | acyl-CoA biosynthetic process (GO:0071616) | 2.45749635 |
| 110 | thioester biosynthetic process (GO:0035384) | 2.45749635 |
| 111 | gap junction assembly (GO:0016264) | 2.45709181 |
| 112 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.44806140 |
| 113 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.44806140 |
| 114 | tonic smooth muscle contraction (GO:0014820) | 2.44201941 |
| 115 | negative regulation of osteoblast proliferation (GO:0033689) | 2.43798641 |
| 116 | sterol biosynthetic process (GO:0016126) | 2.43719608 |
| 117 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.43052020 |
| 118 | plasma lipoprotein particle assembly (GO:0034377) | 2.42078604 |
| 119 | collagen fibril organization (GO:0030199) | 2.41825528 |
| 120 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.41792580 |
| 121 | response to gravity (GO:0009629) | 2.41468546 |
| 122 | glomerular basement membrane development (GO:0032836) | 2.39984765 |
| 123 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.39955212 |
| 124 | one-carbon compound transport (GO:0019755) | 2.39152581 |
| 125 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.38511557 |
| 126 | coenzyme catabolic process (GO:0009109) | 2.38453824 |
| 127 | adhesion of symbiont to host cell (GO:0044650) | 2.37923717 |
| 128 | virion attachment to host cell (GO:0019062) | 2.37923717 |
| 129 | alpha-beta T cell differentiation (GO:0046632) | 2.37836545 |
| 130 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.36447546 |
| 131 | negative regulation of cholesterol transport (GO:0032375) | 2.36265020 |
| 132 | negative regulation of sterol transport (GO:0032372) | 2.36265020 |
| 133 | high-density lipoprotein particle remodeling (GO:0034375) | 2.35746631 |
| 134 | glomerular epithelial cell development (GO:0072310) | 2.34911844 |
| 135 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.34502055 |
| 136 | xenobiotic catabolic process (GO:0042178) | 2.33104741 |
| 137 | glutathione derivative metabolic process (GO:1901685) | 2.32786282 |
| 138 | glutathione derivative biosynthetic process (GO:1901687) | 2.32786282 |
| 139 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.32457388 |
| 140 | negative regulation of complement activation (GO:0045916) | 2.32390779 |
| 141 | negative regulation of protein localization to cell surface (GO:2000009) | 2.32293101 |
| 142 | metanephric mesenchyme development (GO:0072075) | 2.25748813 |
| 143 | left/right pattern formation (GO:0060972) | 2.25249124 |
| 144 | kidney mesenchyme development (GO:0072074) | 2.22197876 |
| 145 | positive regulation of actin filament depolymerization (GO:0030836) | 2.19894490 |
| 146 | sphingosine metabolic process (GO:0006670) | 2.19497257 |
| 147 | endocardial cushion development (GO:0003197) | 2.19387973 |
| 148 | type B pancreatic cell proliferation (GO:0044342) | 2.18827884 |
| 149 | retinal cone cell development (GO:0046549) | 2.18636801 |
| 150 | retinol metabolic process (GO:0042572) | 2.18468051 |
| 151 | cilium morphogenesis (GO:0060271) | 2.18217593 |
| 152 | dermatan sulfate biosynthetic process (GO:0030208) | 2.15438086 |
| 153 | import into cell (GO:0098657) | 2.15283835 |
| 154 | nephron tubule formation (GO:0072079) | 2.13948144 |
| 155 | determination of left/right symmetry (GO:0007368) | 2.12970764 |
| 156 | diol metabolic process (GO:0034311) | 2.12525552 |
| 157 | auditory receptor cell differentiation (GO:0042491) | 2.12305621 |
| 158 | positive regulation of p38MAPK cascade (GO:1900745) | 2.12188190 |
| 159 | regulation of keratinocyte proliferation (GO:0010837) | 2.11183742 |
| 160 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.09441693 |
| 161 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.09263347 |
| 162 | sphingomyelin metabolic process (GO:0006684) | 2.09125775 |
| 163 | membrane assembly (GO:0071709) | 2.09030809 |
| 164 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.08094746 |
| 165 | sleep (GO:0030431) | 2.06990193 |
| 166 | positive regulation of osteoblast proliferation (GO:0033690) | 2.05056978 |
| 167 | regulation of osteoblast proliferation (GO:0033688) | 2.04936253 |
| 168 | cell adhesion mediated by integrin (GO:0033627) | 2.04464534 |
| 169 | glomerular visceral epithelial cell development (GO:0072015) | 2.04414050 |
| 170 | artery smooth muscle contraction (GO:0014824) | 2.02885174 |
| 171 | negative regulation of protein activation cascade (GO:2000258) | 2.01374523 |
| 172 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.01102127 |
| 173 | atrial cardiac muscle cell action potential (GO:0086014) | 2.01015578 |
| 174 | endocrine hormone secretion (GO:0060986) | 1.99884382 |
| 175 | extracellular matrix assembly (GO:0085029) | 1.99617669 |
| 176 | vascular smooth muscle contraction (GO:0014829) | 1.99235852 |
| 177 | keratinocyte proliferation (GO:0043616) | 1.98861753 |
| 178 | cellular potassium ion homeostasis (GO:0030007) | 1.98647167 |
| 179 | determination of bilateral symmetry (GO:0009855) | 1.97692556 |
| 180 | chondrocyte proliferation (GO:0035988) | 1.96744162 |
| 181 | cellular ketone body metabolic process (GO:0046950) | 1.96571830 |
| 182 | regulation of p38MAPK cascade (GO:1900744) | 1.95669428 |
| 183 | specification of symmetry (GO:0009799) | 1.95013565 |
| 184 | ventricular system development (GO:0021591) | 1.94855932 |
| 185 | urinary tract smooth muscle contraction (GO:0014848) | 1.94692850 |
| 186 | peptide hormone processing (GO:0016486) | 1.93720970 |
| 187 | peripheral nervous system development (GO:0007422) | 1.93399773 |
| 188 | regulation of cilium movement (GO:0003352) | 1.93292563 |
| 189 | diterpenoid biosynthetic process (GO:0016102) | 1.93291663 |
| 190 | renal filtration (GO:0097205) | 1.91913863 |
| 191 | thyroid hormone metabolic process (GO:0042403) | 1.91863122 |
| 192 | dermatan sulfate metabolic process (GO:0030205) | 1.91307095 |
| 193 | multicellular organismal water homeostasis (GO:0050891) | 1.91232734 |
| 194 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 1.90677513 |
| 195 | response to redox state (GO:0051775) | 1.90264136 |
| 196 | negative regulation of hormone metabolic process (GO:0032351) | 1.90004704 |
| 197 | cilium organization (GO:0044782) | 1.89892128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.33287689 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.48000692 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.38865457 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.71239118 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.48932653 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.37360867 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.36049303 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.31336840 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.18661285 |
| 10 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.88423649 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.86495720 |
| 12 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.56342186 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.49156526 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.45674827 |
| 15 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.37819045 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.35267959 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.30449969 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.30261331 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.16847893 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.12500507 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09428907 |
| 22 | CJUN_26792858_Chip-Seq_BT549_Human | 2.06714121 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04593687 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03097797 |
| 25 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.99347827 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96969904 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92712221 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.89271191 |
| 29 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.85346764 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.84025406 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.81630360 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.80650179 |
| 33 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.79286072 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.77853252 |
| 35 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.77489060 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77051314 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72914809 |
| 38 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.72235620 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71508378 |
| 40 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.71330348 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71150858 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.70075218 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68915036 |
| 44 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.63503616 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.62404127 |
| 46 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.62404127 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61215233 |
| 48 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.60567829 |
| 49 | TP53_16413492_ChIP-PET_HCT116_Human | 1.56765429 |
| 50 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.55478172 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54827554 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53614582 |
| 53 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.53167734 |
| 54 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52790609 |
| 55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.52383085 |
| 56 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51217739 |
| 57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.49231711 |
| 58 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.45577003 |
| 59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.45249813 |
| 60 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.44982213 |
| 61 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.43905952 |
| 62 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43776403 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42019761 |
| 64 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41954501 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.41646865 |
| 66 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40589681 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40266967 |
| 68 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.39959574 |
| 69 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.38421625 |
| 70 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.38329910 |
| 71 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36618986 |
| 72 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.36443932 |
| 73 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.35085970 |
| 74 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34918229 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34087487 |
| 76 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31461122 |
| 77 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28753754 |
| 78 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28099301 |
| 79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.27117689 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26811484 |
| 81 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.26136357 |
| 82 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.26096536 |
| 83 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.25539830 |
| 84 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.24917882 |
| 85 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.22759956 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22424338 |
| 87 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.22321717 |
| 88 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.21227904 |
| 89 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20342087 |
| 90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.20245696 |
| 91 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.20192119 |
| 92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19713650 |
| 93 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19566664 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.18580784 |
| 95 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18011874 |
| 96 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17755806 |
| 97 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.17190241 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.16704056 |
| 99 | MAF_26560356_Chip-Seq_TH2_Human | 1.15822835 |
| 100 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14972095 |
| 101 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13491854 |
| 102 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13471067 |
| 103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13425027 |
| 104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13244060 |
| 105 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12716034 |
| 106 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11767151 |
| 107 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11004219 |
| 108 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.10799612 |
| 109 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10415103 |
| 110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10186416 |
| 111 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09302389 |
| 112 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09216506 |
| 113 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07338578 |
| 114 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.06644886 |
| 115 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06462983 |
| 116 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04465384 |
| 117 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.04284660 |
| 118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04061688 |
| 119 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04061688 |
| 120 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03421896 |
| 121 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02353166 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02305951 |
| 123 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01389592 |
| 124 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.99982063 |
| 125 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99957682 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99191988 |
| 127 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99139172 |
| 128 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98877806 |
| 129 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98599427 |
| 130 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.98551879 |
| 131 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98448146 |
| 132 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98355219 |
| 133 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98355219 |
| 134 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98217347 |
| 135 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97940190 |
| 136 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96920283 |
| 137 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95367746 |
| 138 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94888724 |
| 139 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94883742 |
| 140 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93142838 |
| 141 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92960124 |
| 142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92686104 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92600531 |
| 144 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92555866 |
| 145 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92274162 |
| 146 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.91994691 |
| 147 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91357673 |
| 148 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91105503 |
| 149 | * FUS_26573619_Chip-Seq_HEK293_Human | 0.90906445 |
| 150 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90329858 |
| 151 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89454825 |
| 152 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88937524 |
| 153 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87391279 |
| 154 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87159303 |
| 155 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86872250 |
| 156 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86782889 |
| 157 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86030792 |
| 158 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83224926 |
| 159 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.82671572 |
| 160 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82108939 |
| 161 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.79832111 |
| 162 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79585466 |
| 163 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.79552067 |
| 164 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78603135 |
| 165 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78176556 |
| 166 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77406822 |
| 167 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.76838068 |
| 168 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76357724 |
| 169 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76230136 |
| 170 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75647819 |
| 171 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.75470276 |
| 172 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75001828 |
| 173 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74904362 |
| 174 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.73966012 |
| 175 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73716362 |
| 176 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73597143 |
| 177 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.72593072 |
| 178 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.71569321 |
| 179 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69684968 |
| 180 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69385782 |
| 181 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68590977 |
| 182 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68467324 |
| 183 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.67943564 |
| 184 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.67943564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.13504224 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.00497708 |
| 3 | MP0003950_abnormal_plasma_membrane | 4.00030682 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.70181935 |
| 5 | MP0005360_urolithiasis | 3.37091966 |
| 6 | MP0005365_abnormal_bile_salt | 3.36623728 |
| 7 | MP0005275_abnormal_skin_tensile | 3.26000939 |
| 8 | MP0005503_abnormal_tendon_morphology | 2.97043214 |
| 9 | MP0004272_abnormal_basement_membrane | 2.88607563 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.85989736 |
| 11 | MP0000685_abnormal_immune_system | 2.77275963 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.67013787 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.65445636 |
| 14 | MP0003279_aneurysm | 2.44634327 |
| 15 | MP0005671_abnormal_response_to | 2.40177470 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.32442229 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.31818778 |
| 18 | MP0004947_skin_inflammation | 2.30805139 |
| 19 | MP0001790_abnormal_immune_system | 2.30372112 |
| 20 | MP0005387_immune_system_phenotype | 2.30372112 |
| 21 | MP0010386_abnormal_urinary_bladder | 2.25116216 |
| 22 | MP0000920_abnormal_myelination | 2.19413657 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 2.17014607 |
| 24 | MP0003252_abnormal_bile_duct | 2.16183608 |
| 25 | MP0009840_abnormal_foam_cell | 2.12116611 |
| 26 | MP0003195_calcinosis | 2.08712449 |
| 27 | MP0001800_abnormal_humoral_immune | 2.06386479 |
| 28 | MP0006082_CNS_inflammation | 2.02615775 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.99291905 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.98271226 |
| 31 | MP0001958_emphysema | 1.96549843 |
| 32 | MP0003879_abnormal_hair_cell | 1.93063285 |
| 33 | MP0001984_abnormal_olfaction | 1.92714588 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.89804180 |
| 35 | MP0003868_abnormal_feces_composition | 1.88043415 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.87305285 |
| 37 | MP0005083_abnormal_biliary_tract | 1.77624894 |
| 38 | MP0005023_abnormal_wound_healing | 1.76480541 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.75141466 |
| 40 | MP0002723_abnormal_immune_serum | 1.74318321 |
| 41 | MP0002693_abnormal_pancreas_physiology | 1.71282251 |
| 42 | MP0004043_abnormal_pH_regulation | 1.70446953 |
| 43 | MP0002295_abnormal_pulmonary_circulatio | 1.67667475 |
| 44 | MP0005171_absent_coat_pigmentation | 1.67564016 |
| 45 | MP0000609_abnormal_liver_physiology | 1.67302130 |
| 46 | MP0003329_amyloid_beta_deposits | 1.66256860 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.65375169 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.61346736 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 1.61126802 |
| 50 | MP0002933_joint_inflammation | 1.59709848 |
| 51 | MP0003690_abnormal_glial_cell | 1.59461763 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.56575956 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.56199129 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.55458831 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.53342310 |
| 56 | MP0003866_abnormal_defecation | 1.52821487 |
| 57 | MP0003941_abnormal_skin_development | 1.52528862 |
| 58 | MP0003283_abnormal_digestive_organ | 1.51825007 |
| 59 | MP0001819_abnormal_immune_cell | 1.50530143 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 1.49496036 |
| 61 | MP0000604_amyloidosis | 1.48525696 |
| 62 | MP0005310_abnormal_salivary_gland | 1.48103192 |
| 63 | MP0005451_abnormal_body_composition | 1.45256929 |
| 64 | MP0002452_abnormal_antigen_presenting | 1.44045167 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.41015114 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.40858664 |
| 67 | MP0001542_abnormal_bone_strength | 1.40660245 |
| 68 | MP0000579_abnormal_nail_morphology | 1.40549628 |
| 69 | MP0002118_abnormal_lipid_homeostasis | 1.39671460 |
| 70 | MP0004381_abnormal_hair_follicle | 1.38920582 |
| 71 | MP0010155_abnormal_intestine_physiology | 1.37844477 |
| 72 | MP0001944_abnormal_pancreas_morphology | 1.36323729 |
| 73 | MP0005332_abnormal_amino_acid | 1.34974847 |
| 74 | MP0002254_reproductive_system_inflammat | 1.34015365 |
| 75 | MP0005595_abnormal_vascular_smooth | 1.32590773 |
| 76 | MP0003724_increased_susceptibility_to | 1.31851448 |
| 77 | MP0000383_abnormal_hair_follicle | 1.29683273 |
| 78 | MP0002405_respiratory_system_inflammati | 1.29247179 |
| 79 | MP0005025_abnormal_response_to | 1.27782032 |
| 80 | MP0001873_stomach_inflammation | 1.26896445 |
| 81 | MP0000716_abnormal_immune_system | 1.26848736 |
| 82 | MP0000538_abnormal_urinary_bladder | 1.26815867 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.25463860 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 1.24498136 |
| 85 | MP0001756_abnormal_urination | 1.24052541 |
| 86 | MP0002006_tumorigenesis | 1.23529475 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 1.23495165 |
| 88 | MP0003566_abnormal_cell_adhesion | 1.20686501 |
| 89 | MP0002653_abnormal_ependyma_morphology | 1.20362881 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 1.20240028 |
| 91 | MP0001835_abnormal_antigen_presentation | 1.20134725 |
| 92 | MP0010352_gastrointestinal_tract_polyps | 1.19344196 |
| 93 | MP0002909_abnormal_adrenal_gland | 1.18461098 |
| 94 | MP0002896_abnormal_bone_mineralization | 1.18044861 |
| 95 | MP0009384_cardiac_valve_regurgitation | 1.17877705 |
| 96 | MP0002398_abnormal_bone_marrow | 1.16763325 |
| 97 | MP0005623_abnormal_meninges_morphology | 1.16676813 |
| 98 | MP0001851_eye_inflammation | 1.16230213 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 1.15488179 |
| 100 | MP0001243_abnormal_dermal_layer | 1.13102352 |
| 101 | MP0003436_decreased_susceptibility_to | 1.12088355 |
| 102 | MP0005058_abnormal_lysosome_morphology | 1.11952259 |
| 103 | MP0005508_abnormal_skeleton_morphology | 1.11273558 |
| 104 | MP0004885_abnormal_endolymph | 1.11010985 |
| 105 | MP0000613_abnormal_salivary_gland | 1.10816674 |
| 106 | MP0005408_hypopigmentation | 1.09963175 |
| 107 | MP0001502_abnormal_circadian_rhythm | 1.08885836 |
| 108 | MP0000427_abnormal_hair_cycle | 1.07745719 |
| 109 | MP0003091_abnormal_cell_migration | 1.07685565 |
| 110 | MP0009785_altered_susceptibility_to | 1.07567001 |
| 111 | MP0001661_extended_life_span | 1.05963847 |
| 112 | MP0009780_abnormal_chondrocyte_physiolo | 1.04725813 |
| 113 | MP0008469_abnormal_protein_level | 1.03662873 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 1.02836136 |
| 115 | MP0000230_abnormal_systemic_arterial | 1.02699635 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 1.02667126 |
| 117 | MP0002108_abnormal_muscle_morphology | 1.02409786 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 1.02380795 |
| 119 | MP0000703_abnormal_thymus_morphology | 1.01332706 |
| 120 | MP0001348_abnormal_lacrimal_gland | 1.00902250 |
| 121 | MP0002078_abnormal_glucose_homeostasis | 1.00728123 |
| 122 | MP0002168_other_aberrant_phenotype | 1.00028255 |
| 123 | MP0005165_increased_susceptibility_to | 0.99053559 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98787446 |
| 125 | MP0003045_fibrosis | 0.98537432 |
| 126 | MP0002419_abnormal_innate_immunity | 0.98346717 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.98232152 |
| 128 | MP0004270_analgesia | 0.96956746 |
| 129 | MP0002272_abnormal_nervous_system | 0.96886816 |
| 130 | MP0000013_abnormal_adipose_tissue | 0.96178564 |
| 131 | MP0000762_abnormal_tongue_morphology | 0.95939850 |
| 132 | MP0005164_abnormal_response_to | 0.94584348 |
| 133 | MP0002148_abnormal_hypersensitivity_rea | 0.93200822 |
| 134 | MP0009250_abnormal_appendicular_skeleto | 0.91882176 |
| 135 | MP0001533_abnormal_skeleton_physiology | 0.91779946 |
| 136 | MP0001299_abnormal_eye_distance/ | 0.91720704 |
| 137 | MP0000689_abnormal_spleen_morphology | 0.90679343 |
| 138 | MP0001765_abnormal_ion_homeostasis | 0.90465210 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.90310038 |
| 140 | MP0002998_abnormal_bone_remodeling | 0.89924231 |
| 141 | MP0009046_muscle_twitch | 0.89122114 |
| 142 | MP0004147_increased_porphyrin_level | 0.89109292 |
| 143 | MP0001853_heart_inflammation | 0.88516513 |
| 144 | MP0000749_muscle_degeneration | 0.88330727 |
| 145 | MP0002429_abnormal_blood_cell | 0.87650673 |
| 146 | MP0002722_abnormal_immune_system | 0.86992498 |
| 147 | MP0004510_myositis | 0.86873882 |
| 148 | MP0001664_abnormal_digestion | 0.86660904 |
| 149 | MP0000003_abnormal_adipose_tissue | 0.85487624 |
| 150 | MP0004215_abnormal_myocardial_fiber | 0.83512738 |
| 151 | MP0002136_abnormal_kidney_physiology | 0.82817086 |
| 152 | MP0003191_abnormal_cellular_cholesterol | 0.81385718 |
| 153 | MP0004133_heterotaxia | 0.81211433 |
| 154 | MP0004264_abnormal_extraembryonic_tissu | 0.81156431 |
| 155 | MP0005620_abnormal_muscle_contractility | 0.80705092 |
| 156 | MP0000462_abnormal_digestive_system | 0.80059857 |
| 157 | MP0006054_spinal_hemorrhage | 0.79794555 |
| 158 | MP0000569_abnormal_digit_pigmentation | 0.79239089 |
| 159 | MP0009763_increased_sensitivity_to | 0.78970907 |
| 160 | MP0005636_abnormal_mineral_homeostasis | 0.78500895 |
| 161 | MP0003136_yellow_coat_color | 0.77950815 |
| 162 | MP0010030_abnormal_orbit_morphology | 0.76399522 |
| 163 | MP0002060_abnormal_skin_morphology | 0.75123808 |
| 164 | MP0001216_abnormal_epidermal_layer | 0.75065899 |
| 165 | MP0002796_impaired_skin_barrier | 0.73939899 |
| 166 | MP0010771_integument_phenotype | 0.73911121 |
| 167 | MP0000767_abnormal_smooth_muscle | 0.73743913 |
| 168 | MP0005367_renal/urinary_system_phenotyp | 0.72124549 |
| 169 | MP0000516_abnormal_urinary_system | 0.72124549 |
| 170 | MP0000534_abnormal_ureter_morphology | 0.71513846 |
| 171 | MP0009745_abnormal_behavioral_response | 0.71380842 |
| 172 | MP0004883_abnormal_blood_vessel | 0.67112518 |
| 173 | MP0002938_white_spotting | 0.64484498 |
| 174 | MP0001970_abnormal_pain_threshold | 0.64302960 |
| 175 | MP0002282_abnormal_trachea_morphology | 0.64214725 |
| 176 | MP0003633_abnormal_nervous_system | 0.63754002 |
| 177 | MP0003075_altered_response_to | 0.62433723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal ciliary motility (HP:0012262) | 5.45389818 |
| 2 | Abnormal respiratory motile cilium physiology (HP:0012261) | 5.20170051 |
| 3 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.89254471 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.75408545 |
| 5 | T lymphocytopenia (HP:0005403) | 4.73410760 |
| 6 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.72800453 |
| 7 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.72800453 |
| 8 | Stomatitis (HP:0010280) | 4.67656193 |
| 9 | Absent/shortened dynein arms (HP:0200106) | 4.60047665 |
| 10 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.60047665 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.54133784 |
| 12 | Rhinitis (HP:0012384) | 4.36963968 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 4.23887370 |
| 14 | Hypoglycemic coma (HP:0001325) | 4.05084245 |
| 15 | Hypoglycemic seizures (HP:0002173) | 3.86384741 |
| 16 | Xanthomatosis (HP:0000991) | 3.71698557 |
| 17 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.69904074 |
| 18 | Symptomatic seizures (HP:0011145) | 3.46907264 |
| 19 | Premature rupture of membranes (HP:0001788) | 3.40729088 |
| 20 | Cardiovascular calcification (HP:0011915) | 3.36854317 |
| 21 | Protrusio acetabuli (HP:0003179) | 3.31518197 |
| 22 | Ketoacidosis (HP:0001993) | 3.24858713 |
| 23 | Severe combined immunodeficiency (HP:0004430) | 3.24206604 |
| 24 | Conjugated hyperbilirubinemia (HP:0002908) | 3.20808825 |
| 25 | Neurofibrillary tangles (HP:0002185) | 3.19523422 |
| 26 | Popliteal pterygium (HP:0009756) | 3.18501359 |
| 27 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.16071356 |
| 28 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.16071356 |
| 29 | Hyperlipoproteinemia (HP:0010980) | 3.13735551 |
| 30 | Hypobetalipoproteinemia (HP:0003563) | 3.13094144 |
| 31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.08683582 |
| 32 | Ketosis (HP:0001946) | 3.06415541 |
| 33 | Aortic dissection (HP:0002647) | 3.05967905 |
| 34 | Bronchiectasis (HP:0002110) | 3.04668606 |
| 35 | Fat malabsorption (HP:0002630) | 3.02677806 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.02448387 |
| 37 | Abnormality of T cells (HP:0002843) | 3.00363625 |
| 38 | Deep venous thrombosis (HP:0002625) | 2.99627421 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 2.94026178 |
| 40 | Chronic diarrhea (HP:0002028) | 2.92337680 |
| 41 | Aortic aneurysm (HP:0004942) | 2.91328387 |
| 42 | Vascular calcification (HP:0004934) | 2.90468018 |
| 43 | Recurrent bronchitis (HP:0002837) | 2.90029368 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.89870828 |
| 45 | Abnormality of dentin (HP:0010299) | 2.87584573 |
| 46 | Chronic otitis media (HP:0000389) | 2.86600449 |
| 47 | Chronic bronchitis (HP:0004469) | 2.81291497 |
| 48 | Nasal polyposis (HP:0100582) | 2.81220501 |
| 49 | Late onset (HP:0003584) | 2.80515228 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.80070383 |
| 51 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.76204098 |
| 52 | Atrophic scars (HP:0001075) | 2.74502133 |
| 53 | Vascular tortuosity (HP:0004948) | 2.74129939 |
| 54 | Follicular hyperkeratosis (HP:0007502) | 2.71029488 |
| 55 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.61697947 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.59737215 |
| 57 | Tubular atrophy (HP:0000092) | 2.59055457 |
| 58 | Generalized aminoaciduria (HP:0002909) | 2.58417318 |
| 59 | Large for gestational age (HP:0001520) | 2.52706520 |
| 60 | Autoimmune hemolytic anemia (HP:0001890) | 2.51806420 |
| 61 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.51078085 |
| 62 | Hypoplasia of the thymus (HP:0000778) | 2.50854417 |
| 63 | Abnormality of the intrinsic pathway (HP:0010989) | 2.49985036 |
| 64 | IgG deficiency (HP:0004315) | 2.47853864 |
| 65 | Spondylolisthesis (HP:0003302) | 2.43722048 |
| 66 | Arterial tortuosity (HP:0005116) | 2.41691767 |
| 67 | Pancreatic fibrosis (HP:0100732) | 2.41403245 |
| 68 | Glucose intolerance (HP:0000833) | 2.39929887 |
| 69 | Hyperglycemia (HP:0003074) | 2.38121486 |
| 70 | Abnormality of eosinophils (HP:0001879) | 2.37926385 |
| 71 | Thyroiditis (HP:0100646) | 2.33244704 |
| 72 | Steatorrhea (HP:0002570) | 2.33103674 |
| 73 | Premature skin wrinkling (HP:0100678) | 2.32508201 |
| 74 | Recurrent sinusitis (HP:0011108) | 2.30989620 |
| 75 | Pancreatic cysts (HP:0001737) | 2.30525771 |
| 76 | Gastrointestinal stroma tumor (HP:0100723) | 2.27997104 |
| 77 | Neonatal short-limb short stature (HP:0008921) | 2.22526596 |
| 78 | Acute hepatic failure (HP:0006554) | 2.20347780 |
| 79 | Recurrent viral infections (HP:0004429) | 2.18107542 |
| 80 | Abnormality of midbrain morphology (HP:0002418) | 2.16458622 |
| 81 | Molar tooth sign on MRI (HP:0002419) | 2.16458622 |
| 82 | Increased IgM level (HP:0003496) | 2.15965580 |
| 83 | Pancreatitis (HP:0001733) | 2.15327823 |
| 84 | Cerebral inclusion bodies (HP:0100314) | 2.12846283 |
| 85 | Abnormality of B cell number (HP:0010975) | 2.12291740 |
| 86 | B lymphocytopenia (HP:0010976) | 2.12291740 |
| 87 | Broad metatarsal (HP:0001783) | 2.11758576 |
| 88 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.11686610 |
| 89 | Abnormality of glycine metabolism (HP:0010895) | 2.11686610 |
| 90 | Abnormality of proline metabolism (HP:0010907) | 2.11264309 |
| 91 | Hydroxyprolinuria (HP:0003080) | 2.11264309 |
| 92 | True hermaphroditism (HP:0010459) | 2.11172337 |
| 93 | Bell-shaped thorax (HP:0001591) | 2.10632712 |
| 94 | Nephronophthisis (HP:0000090) | 2.10554514 |
| 95 | Protuberant abdomen (HP:0001538) | 2.09666542 |
| 96 | Abnormality of the nasal mucosa (HP:0000433) | 2.08579093 |
| 97 | Lymphopenia (HP:0001888) | 2.08055120 |
| 98 | Abnormal glucose tolerance (HP:0001952) | 2.08018917 |
| 99 | Sensory axonal neuropathy (HP:0003390) | 2.07964640 |
| 100 | Myocardial infarction (HP:0001658) | 2.07110732 |
| 101 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.06644113 |
| 102 | Short nail (HP:0001799) | 2.06249216 |
| 103 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.06095660 |
| 104 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.05546935 |
| 105 | Medial flaring of the eyebrow (HP:0010747) | 2.05504539 |
| 106 | IgM deficiency (HP:0002850) | 2.05342074 |
| 107 | Epidermoid cyst (HP:0200040) | 2.04581007 |
| 108 | Eosinophilia (HP:0001880) | 2.04328773 |
| 109 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.03977324 |
| 110 | Abnormality of T cell physiology (HP:0011840) | 2.03877462 |
| 111 | Coronal craniosynostosis (HP:0004440) | 2.03416037 |
| 112 | Joint swelling (HP:0001386) | 2.00928546 |
| 113 | Hypolipoproteinemia (HP:0010981) | 1.99977884 |
| 114 | Stage 5 chronic kidney disease (HP:0003774) | 1.98495239 |
| 115 | Soft skin (HP:0000977) | 1.98182691 |
| 116 | Abnormality of molar morphology (HP:0011070) | 1.98131506 |
| 117 | Abnormality of molar (HP:0011077) | 1.98131506 |
| 118 | Abnormal foot bone ossification (HP:0010675) | 1.98001923 |
| 119 | Mucopolysacchariduria (HP:0008155) | 1.97619426 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97619426 |
| 121 | Cystic liver disease (HP:0006706) | 1.97432735 |
| 122 | Action tremor (HP:0002345) | 1.97130356 |
| 123 | Vacuolated lymphocytes (HP:0001922) | 1.97128881 |
| 124 | Abdominal distention (HP:0003270) | 1.96803395 |
| 125 | Hyperammonemia (HP:0001987) | 1.93357560 |
| 126 | Hemiparesis (HP:0001269) | 1.92906446 |
| 127 | Congenital sensorineural hearing impairment (HP:0008527) | 1.92895337 |
| 128 | Mitral stenosis (HP:0001718) | 1.92867737 |
| 129 | Occipital encephalocele (HP:0002085) | 1.92643093 |
| 130 | Hyperglycinuria (HP:0003108) | 1.92241953 |
| 131 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.92106629 |
| 132 | Gastrointestinal infarctions (HP:0005244) | 1.91248259 |
| 133 | Metabolic alkalosis (HP:0200114) | 1.91236050 |
| 134 | Delayed gross motor development (HP:0002194) | 1.91115654 |
| 135 | Abnormality of methionine metabolism (HP:0010901) | 1.91057720 |
| 136 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.88429046 |
| 137 | Furrowed tongue (HP:0000221) | 1.87259218 |
| 138 | Increased CSF protein (HP:0002922) | 1.86699446 |
| 139 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.86153871 |
| 140 | Infertility (HP:0000789) | 1.85364070 |
| 141 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.85190194 |
| 142 | Recurrent fungal infections (HP:0002841) | 1.84080370 |
| 143 | Metaphyseal dysplasia (HP:0100255) | 1.83876188 |
| 144 | Pulmonary embolism (HP:0002204) | 1.83452314 |
| 145 | Nonprogressive disorder (HP:0003680) | 1.83308785 |
| 146 | IgA deficiency (HP:0002720) | 1.83248824 |
| 147 | Abnormality of the renal medulla (HP:0100957) | 1.82878540 |
| 148 | Limb hypertonia (HP:0002509) | 1.82615086 |
| 149 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.82522557 |
| 150 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.82522557 |
| 151 | Hypoplastic labia majora (HP:0000059) | 1.81637047 |
| 152 | Aplasia of the musculature (HP:0100854) | 1.81631950 |
| 153 | Abnormality of the dental pulp (HP:0006479) | 1.77558630 |
| 154 | Bronchitis (HP:0012387) | 1.77384052 |
| 155 | Chronic sinusitis (HP:0011109) | 1.77086653 |
| 156 | Wormian bones (HP:0002645) | 1.77084032 |
| 157 | Renal cortical cysts (HP:0000803) | 1.76873197 |
| 158 | Vasculitis (HP:0002633) | 1.75747341 |
| 159 | Peripheral hypomyelination (HP:0007182) | 1.75723637 |
| 160 | Abnormal tarsal ossification (HP:0008369) | 1.75386053 |
| 161 | Gait imbalance (HP:0002141) | 1.75309203 |
| 162 | Cervical subluxation (HP:0003308) | 1.75186006 |
| 163 | Parakeratosis (HP:0001036) | 1.74796522 |
| 164 | Panhypogammaglobulinemia (HP:0003139) | 1.74561186 |
| 165 | Bradycardia (HP:0001662) | 1.74527411 |
| 166 | Bladder diverticulum (HP:0000015) | 1.73601631 |
| 167 | Abnormal drinking behavior (HP:0030082) | 1.73536510 |
| 168 | Polydipsia (HP:0001959) | 1.73536510 |
| 169 | Abnormality of the dental root (HP:0006486) | 1.71999201 |
| 170 | Taurodontia (HP:0000679) | 1.71999201 |
| 171 | Abnormality of permanent molar morphology (HP:0011071) | 1.71999201 |
| 172 | Hypothermia (HP:0002045) | 1.69275985 |
| 173 | Tubulointerstitial fibrosis (HP:0005576) | 1.68426015 |
| 174 | Right ventricular cardiomyopathy (HP:0011663) | 1.68058001 |
| 175 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.67625431 |
| 176 | Abnormality of the labia majora (HP:0012881) | 1.66851716 |
| 177 | Hyperactive renin-angiotensin system (HP:0000841) | 1.65601380 |
| 178 | Short hallux (HP:0010109) | 1.65462899 |
| 179 | Congenital primary aphakia (HP:0007707) | 1.65365189 |
| 180 | Pigmentary retinal degeneration (HP:0001146) | 1.61543848 |
| 181 | Short thorax (HP:0010306) | 1.59652632 |
| 182 | Increased circulating renin level (HP:0000848) | 1.59542488 |
| 183 | Abnormality of the renal cortex (HP:0011035) | 1.56844498 |
| 184 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.56641103 |
| 185 | Aplasia of the phalanges of the hand (HP:0009802) | 1.56641103 |
| 186 | Aplasia involving bones of the extremities (HP:0009825) | 1.56641103 |
| 187 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.56498877 |
| 188 | Overgrowth (HP:0001548) | 1.54532589 |
| 189 | Pterygium (HP:0001059) | 1.54326304 |
| 190 | Hyporeflexia of lower limbs (HP:0002600) | 1.52596293 |
| 191 | Shallow orbits (HP:0000586) | 1.52372846 |
| 192 | Fragile skin (HP:0001030) | 1.51667693 |
| 193 | Increased corneal curvature (HP:0100692) | 1.51521255 |
| 194 | Keratoconus (HP:0000563) | 1.51521255 |
| 195 | Aortic regurgitation (HP:0001659) | 1.51474887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.72130440 |
| 2 | ITK | 3.57343787 |
| 3 | MYLK | 3.19097010 |
| 4 | TXK | 3.14992521 |
| 5 | STK38L | 3.10695947 |
| 6 | EPHB1 | 3.02416189 |
| 7 | FGFR4 | 2.97005019 |
| 8 | MST4 | 2.84299884 |
| 9 | MUSK | 2.81974922 |
| 10 | LATS1 | 2.71267499 |
| 11 | STK24 | 2.70957945 |
| 12 | ACVR1B | 2.48687234 |
| 13 | JAK3 | 2.38636190 |
| 14 | NLK | 2.24885404 |
| 15 | STK39 | 2.19870033 |
| 16 | MAP3K12 | 2.17657597 |
| 17 | MST1R | 2.15004073 |
| 18 | IKBKE | 2.13230223 |
| 19 | ERN1 | 2.12207950 |
| 20 | MAP3K14 | 2.09292117 |
| 21 | STK10 | 2.04430896 |
| 22 | TYK2 | 1.99432829 |
| 23 | AKT3 | 1.98409595 |
| 24 | STK38 | 1.98343360 |
| 25 | INSRR | 1.98212362 |
| 26 | PTK2B | 1.97208773 |
| 27 | JAK1 | 1.94234349 |
| 28 | PRKD3 | 1.92943631 |
| 29 | TRPM7 | 1.92618691 |
| 30 | BMPR1B | 1.90963723 |
| 31 | MAPKAPK3 | 1.86469088 |
| 32 | EPHA2 | 1.83359412 |
| 33 | EPHA3 | 1.81334293 |
| 34 | GRK6 | 1.79233186 |
| 35 | NEK9 | 1.73554565 |
| 36 | LATS2 | 1.71499935 |
| 37 | DDR2 | 1.69913886 |
| 38 | DAPK2 | 1.69210607 |
| 39 | SIK1 | 1.65934811 |
| 40 | GRK1 | 1.62306972 |
| 41 | IRAK1 | 1.61208118 |
| 42 | PINK1 | 1.61193708 |
| 43 | MAP4K2 | 1.60337024 |
| 44 | TAOK3 | 1.60111847 |
| 45 | CASK | 1.55245871 |
| 46 | ZAP70 | 1.54792514 |
| 47 | WNK4 | 1.51734152 |
| 48 | MAPK15 | 1.49948455 |
| 49 | TBK1 | 1.48575793 |
| 50 | FGFR2 | 1.44479592 |
| 51 | CSK | 1.43376555 |
| 52 | PRKCQ | 1.39466904 |
| 53 | LIMK1 | 1.39390542 |
| 54 | MAP3K13 | 1.35059416 |
| 55 | PRKCH | 1.34646139 |
| 56 | HIPK2 | 1.34593029 |
| 57 | PRPF4B | 1.32198438 |
| 58 | TEC | 1.32065661 |
| 59 | PKN1 | 1.29929501 |
| 60 | TYRO3 | 1.27797913 |
| 61 | IRAK3 | 1.27151961 |
| 62 | LCK | 1.25175420 |
| 63 | STK3 | 1.21739165 |
| 64 | BTK | 1.21562461 |
| 65 | PDGFRA | 1.20886270 |
| 66 | MAP3K3 | 1.19439640 |
| 67 | PTK6 | 1.19403840 |
| 68 | FGFR3 | 1.19060507 |
| 69 | PIK3CA | 1.16878292 |
| 70 | BCKDK | 1.16668358 |
| 71 | PRKCE | 1.14928557 |
| 72 | IRAK4 | 1.14248681 |
| 73 | IKBKB | 1.08886904 |
| 74 | MET | 1.07914165 |
| 75 | PRKD2 | 1.07254860 |
| 76 | IRAK2 | 1.04587753 |
| 77 | ADRBK1 | 1.02379106 |
| 78 | JAK2 | 1.01489588 |
| 79 | MAP3K2 | 1.01162615 |
| 80 | PASK | 0.96229996 |
| 81 | NTRK1 | 0.93743942 |
| 82 | MAP2K1 | 0.93267598 |
| 83 | TRIB3 | 0.92192752 |
| 84 | TNIK | 0.89058833 |
| 85 | PDGFRB | 0.88832342 |
| 86 | ABL2 | 0.88387927 |
| 87 | OXSR1 | 0.88271287 |
| 88 | FLT3 | 0.87557341 |
| 89 | ADRBK2 | 0.86661372 |
| 90 | ROCK1 | 0.85750155 |
| 91 | FER | 0.85159961 |
| 92 | TGFBR1 | 0.85157363 |
| 93 | PHKG2 | 0.84317058 |
| 94 | PHKG1 | 0.84317058 |
| 95 | ERBB3 | 0.81939582 |
| 96 | MARK3 | 0.81674008 |
| 97 | PRKG2 | 0.81610600 |
| 98 | LRRK2 | 0.81113034 |
| 99 | MAP3K10 | 0.81013845 |
| 100 | CAMK2G | 0.79142438 |
| 101 | RIPK1 | 0.78008361 |
| 102 | CAMK2D | 0.77933571 |
| 103 | CHUK | 0.77610305 |
| 104 | FRK | 0.77352658 |
| 105 | HCK | 0.75991147 |
| 106 | NUAK1 | 0.73752424 |
| 107 | TESK1 | 0.72391427 |
| 108 | ERBB4 | 0.69821634 |
| 109 | ARAF | 0.67838989 |
| 110 | MAPKAPK5 | 0.66206796 |
| 111 | MAP2K2 | 0.66123043 |
| 112 | ILK | 0.65300217 |
| 113 | PTK2 | 0.64913322 |
| 114 | PAK3 | 0.64880425 |
| 115 | CLK1 | 0.63852832 |
| 116 | WNK1 | 0.63612803 |
| 117 | CAMK2A | 0.62996734 |
| 118 | EIF2AK3 | 0.62246699 |
| 119 | PIK3CG | 0.61643776 |
| 120 | MELK | 0.60858281 |
| 121 | MAPK7 | 0.59845969 |
| 122 | TESK2 | 0.59540761 |
| 123 | UHMK1 | 0.58966980 |
| 124 | PRKD1 | 0.57590018 |
| 125 | MAP3K7 | 0.56993947 |
| 126 | NTRK3 | 0.55502999 |
| 127 | INSR | 0.54611202 |
| 128 | CSNK1A1L | 0.53803127 |
| 129 | BRSK2 | 0.51801873 |
| 130 | GSK3A | 0.51358036 |
| 131 | CSNK1G1 | 0.49119488 |
| 132 | MAP2K6 | 0.49119195 |
| 133 | RPS6KA5 | 0.48315230 |
| 134 | MARK2 | 0.48119109 |
| 135 | PAK2 | 0.47872457 |
| 136 | CAMKK1 | 0.47645701 |
| 137 | SYK | 0.47434024 |
| 138 | BCR | 0.46791533 |
| 139 | IGF1R | 0.46636945 |
| 140 | MOS | 0.46137076 |
| 141 | PDK1 | 0.45383565 |
| 142 | PDK2 | 0.44786112 |
| 143 | LMTK2 | 0.44669003 |
| 144 | ROCK2 | 0.44157358 |
| 145 | NEK6 | 0.43946679 |
| 146 | FES | 0.43883738 |
| 147 | MAP3K1 | 0.43235887 |
| 148 | PIM2 | 0.42595163 |
| 149 | PRKCG | 0.41004169 |
| 150 | SGK2 | 0.40004125 |
| 151 | CAMK1 | 0.39613421 |
| 152 | SGK223 | 0.39052987 |
| 153 | SGK494 | 0.39052987 |
| 154 | CSNK1G3 | 0.39026178 |
| 155 | LYN | 0.38132946 |
| 156 | TGFBR2 | 0.37271037 |
| 157 | MAPK12 | 0.36372314 |
| 158 | ABL1 | 0.36289367 |
| 159 | MAP3K4 | 0.36203652 |
| 160 | FYN | 0.35904348 |
| 161 | DMPK | 0.35544587 |
| 162 | PAK4 | 0.35069883 |
| 163 | CAMK2B | 0.34577531 |
| 164 | PRKAA2 | 0.34129452 |
| 165 | DYRK1B | 0.30767479 |
| 166 | PDPK1 | 0.30459357 |
| 167 | FGFR1 | 0.29943545 |
| 168 | MAPK11 | 0.28558233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.93784513 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.14274141 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.12690609 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.82913832 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.51388030 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.24933253 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.24811246 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.20878137 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.18889140 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.09805972 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.08507855 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90651449 |
| 13 | Mineral absorption_Homo sapiens_hsa04978 | 1.90360836 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.89711436 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.88698631 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 1.88206394 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78058871 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.77715615 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74149894 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.60140164 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.59251843 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.54827821 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53830390 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.53615224 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.52802704 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50044831 |
| 27 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.48608398 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.43744984 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42844731 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.40926824 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.40168626 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.34827220 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34271874 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.33971636 |
| 35 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.28509633 |
| 36 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.27015256 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25685066 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 1.23725232 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.23463489 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20974783 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.19662512 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14333552 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11897160 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10871984 |
| 45 | Focal adhesion_Homo sapiens_hsa04510 | 1.09970323 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06696938 |
| 47 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.05708292 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05126759 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.05041988 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04679791 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01093927 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00837751 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00770596 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.00751139 |
| 55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99672679 |
| 56 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99584808 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99107116 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99049665 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98906069 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97109086 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96507441 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.96201957 |
| 63 | Tight junction_Homo sapiens_hsa04530 | 0.95854229 |
| 64 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.95157172 |
| 65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94973704 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94564133 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94179820 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93884383 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.92512618 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91920710 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90367424 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88450655 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87876783 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86089724 |
| 75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.85778836 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.84557495 |
| 77 | GABAergic synapse_Homo sapiens_hsa04727 | 0.83084338 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79958807 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78726962 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.78068108 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77675643 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.77566856 |
| 83 | Phototransduction_Homo sapiens_hsa04744 | 0.75882496 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75836973 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75748762 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 0.75663601 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74526961 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74458852 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74098603 |
| 90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.73630630 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73423435 |
| 92 | Nicotine addiction_Homo sapiens_hsa05033 | 0.72529285 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.72300488 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72111365 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71911552 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71868419 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71374906 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71322687 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70454411 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68610274 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68517075 |
| 102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67867895 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.66998511 |
| 104 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66828439 |
| 105 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.66687480 |
| 106 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65244460 |
| 107 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65179054 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65113295 |
| 109 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.64449625 |
| 110 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64281446 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63525374 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62197878 |
| 113 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61210535 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61089948 |
| 115 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60632252 |
| 116 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60604633 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60391092 |
| 118 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57959430 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57951617 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57936312 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56807095 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56392062 |
| 123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55816149 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54217237 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54143186 |
| 126 | Lysosome_Homo sapiens_hsa04142 | 0.53500621 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52691343 |
| 128 | Lysine degradation_Homo sapiens_hsa00310 | 0.52076541 |
| 129 | Amoebiasis_Homo sapiens_hsa05146 | 0.52064372 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51397562 |
| 131 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.51068128 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49671205 |
| 133 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49296996 |
| 134 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.48557554 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47736804 |
| 136 | Adherens junction_Homo sapiens_hsa04520 | 0.47515655 |
| 137 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46926341 |
| 138 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46608354 |
| 139 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46552133 |
| 140 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45662639 |
| 141 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45498065 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45496829 |
| 143 | Taste transduction_Homo sapiens_hsa04742 | 0.45027551 |
| 144 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42832266 |
| 145 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42594522 |
| 146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41574061 |
| 147 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.40104413 |
| 148 | Prion diseases_Homo sapiens_hsa05020 | 0.40078376 |
| 149 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39770117 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39584382 |
| 151 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35648686 |
| 152 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.34046401 |
| 153 | Insulin secretion_Homo sapiens_hsa04911 | 0.33868655 |
| 154 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32835746 |
| 155 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31192915 |
| 156 | Prostate cancer_Homo sapiens_hsa05215 | 0.28617980 |
| 157 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28592999 |

